Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: NMR Biomed. 2013 Sep 4;26(12):10.1002/nbm.3014. doi: 10.1002/nbm.3014

Fig. 2.

Fig. 2

Axial RARE T2-weighted images of mice pancreatic cancer xenografts in four groups receiving different treatments, showing homogeneous hyperintense tumor masses on the unilateral back of mice (arrows). Follow-up of tumor growths at different time points shows that, compared with the PBS (A-D), chemotherapy-only (I-L) and RFH-only (E-H) groups, the tumor size in the group treated by RFH-enhanced chemotherapy (M-P) was significantly decreased.